Sorrento Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Sorrento Therapeutics, Inc.(2.6%)
Sorrento Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Sorrento Therapeutics, Inc.
Sorrento Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Sorrento Therapeutics, Inc.(1.3%)
Sorrento Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Sorrento Therapeutics, Inc.
Sorrento Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Sorrento Therapeutics, Inc.(43.3%)
Sorrento Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Ji Henry
Sorrento Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-STATE STREET CORPORATION(0.03%)
Sorrento Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(0.0%)
Sorrento Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Sorrento Therapeutics, Inc.(44.2%)
Sorrento Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Millennium Management LLC(3.1%),Millennium Group Management LLC(3.1%), etc.
Sorrento Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-STATE STREET CORPORATION(10.73%),SSGA FUNDS MANAGEMENT, INC.(8.78%)
Sorrento Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(6.26%)
Sorrento Therapeutics | 5: Annual statement of changes in beneficial ownership of securities-Director Janda Kim
Sorrento Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(8.4%)
Sorrento Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Sorrento Therapeutics, Inc.(45.5%)
Sorrento Therapeutics | 4: Statement of changes in beneficial ownership of securities
Sorrento Therapeutics | 4: Statement of changes in beneficial ownership of securities
Sorrento Therapeutics | 4: Statement of changes in beneficial ownership of securities
Sorrento Therapeutics | 4: Statement of changes in beneficial ownership of securities
Sorrento Therapeutics | 4: Statement of changes in beneficial ownership of securities
No Data
No Data